Results for untargeted MS search on m/z: (+/-) mode (maximum rows displayed:1000)
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN004246 | 36.25381673 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 37.86117907 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 37.87762412 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 37.91146227 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 37.92875285 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 37.94488208 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 37.96213529 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.11316588 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.14695674 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.16429489 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.18107379 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.19738131 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.21495629 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.23099767 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.24829287 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.28173098 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.39954969 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.41657803 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.43326347 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.45146273 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.46657477 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.48405952 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.50075919 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 38.69589099 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 40.92188479 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 40.96723857 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 41.23836786 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 46.88986247 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 48.09095134 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 49.53183725 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 49.59935309 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 50.84870086 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 52.11113909 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 52.21149847 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 52.59080846 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 52.83716638 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 53.13671802 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 53.46970664 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 54.23008604 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 57.35370385 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 57.42629174 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 57.50670762 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 58.0246375 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 58.46918264 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 58.72332721 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 60.99677874 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 63.81677912 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 64.93702886 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 65.04036437 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 66.47902233 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 68.68796313 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 69.81778608 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 69.83590997 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 69.89381279 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 70.72668138 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 71.27876485 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 71.30652389 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 73.30898463 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 74.00124935 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 74.2417741 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 74.25929146 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 75.04403066 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 76.29524933 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 76.90145412 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 77.30307717 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 80.59448361 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 80.70293031 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 80.94786535 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 80.97366502 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 81.22428844 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 81.5209274 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 81.5210689 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 82.02236276 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 82.25920167 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 82.94501336 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 83.51759537 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.04449698 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.04453177 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.08124264 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.34302821 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.91135876 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.93893036 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.95947424 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.95981173 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.95982559 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.95986419 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.95987994 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.95989141 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.9599068 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.95992774 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 84.97930116 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 85.02848524 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 85.04787012 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 85.05898601 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 85.0591516 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 85.05931567 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 85.05952181 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 85.10126678 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.01836788 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.03342223 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.06018325 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.09633008 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.09656025 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.09660211 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.65479489 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.77183811 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.82640107 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.85364984 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.93528835 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.94140389 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 86.99273947 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.04432217 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.05539301 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.09978106 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.09984185 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.26191353 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.28854003 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.34278033 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.51009618 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 87.96032087 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.01101366 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.01136375 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.01159385 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.01221408 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.02056311 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.02154133 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.02168135 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.03936767 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.03947951 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.03949168 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.05081834 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.07537937 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.07582712 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.07587462 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.07594455 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.07645383 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.07685024 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.11245457 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.50961315 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.50973235 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.95166964 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.96632183 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 88.98164846 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.00889576 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.02408392 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.0393057 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.05967944 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.05974034 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.05976755 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.05977621 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.05986152 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.05994468 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.07941457 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.46543042 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.46545269 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.46569898 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.46573334 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50698435 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.5069965 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50704915 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50705019 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.5070619 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.507062 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50706833 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50707119 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50707629 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50712335 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50718628 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.50721648 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 89.7928827 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.00824954 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.01728865 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.05503354 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.09172445 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50718219 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50718439 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.5071888 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50720036 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50720097 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50720224 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50720349 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.5072041 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50720915 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50721327 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.5072162 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50722725 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50723029 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50723043 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50723334 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50723592 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50723895 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50726659 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50732649 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50733603 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.50748195 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.52620948 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.97664928 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.97669732 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 90.9770279 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.0085553 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.00883568 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.01462112 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.01824655 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.05423196 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.05425201 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.05426942 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.05441772 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.05458794 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.05602393 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.05802229 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50491427 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50495027 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50495921 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50498679 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50498751 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50505884 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50506408 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.50522992 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 91.98009902 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.00585602 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.00602343 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.01628965 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.05750878 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.05756679 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.05922617 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.50404626 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.96645821 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 92.98102923 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.00515595 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.0334932 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.04452418 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.05462843 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.05466249 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.05488243 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.05497703 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.0699658 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.06999168 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.07026822 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.0702819 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.50393676 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.50399509 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.50408804 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 93.97404009 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.00416601 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.05875359 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.06528069 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.50292977 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.9655106 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.96559225 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.96567491 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 94.965734 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.00852466 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.01324124 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.04907705 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.04919343 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.04925223 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.04932199 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.04954338 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.05903496 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.06107926 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.06134923 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.06695204 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08523789 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08553061 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08554405 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08555195 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08556909 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08558785 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08558814 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08562885 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08563164 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08563468 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08565269 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08565698 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.085659 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08570876 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.08570984 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.50238694 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97340433 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97342818 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97350082 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97350548 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.9735751 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.973578 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97360194 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97360726 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97366196 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 95.97382346 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.01191235 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.04403667 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.0785522 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.08096688 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.08842088 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.08874763 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.0889099 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.51482805 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.51494074 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.51533692 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.92185957 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.93769436 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.96094171 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.9609832 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.96100541 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.96103188 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.96106379 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.96106982 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.96109849 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.96112457 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 96.97200752 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.01640726 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.02838902 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.02842831 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.02849781 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.0285536 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.0285679 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.02859357 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.02861322 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.02868302 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.06497292 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.06554522 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.07623009 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.0762401 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10035098 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10118587 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10123958 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10127659 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10130091 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10132594 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10133398 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10133421 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10139889 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.10147142 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.51444065 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.51452246 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.51474179 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.52182292 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.52853671 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.52940739 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.95368474 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96802729 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96879441 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96882222 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96886658 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96887518 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96888216 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96889882 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 97.96893457 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.01391554 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.0140773 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.01420544 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.0142255 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.02162394 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.03178813 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.03190875 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.06023573 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.06056489 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.06137771 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.07041318 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.0716017 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.07179073 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.09651723 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.09664962 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.51163467 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.51227871 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.5124082 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.51246703 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.5124777 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.51247861 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.51259676 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.91913681 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.93869741 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.96159626 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.96334966 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.96344038 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.9638636 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.96411182 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.96724491 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.97128913 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 98.98431549 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.0127856 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.01361187 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.04411094 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.04412434 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.0441728 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05529822 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05535604 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.0553663 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05537322 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05542153 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05542322 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05543147 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05546171 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05548757 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.05551435 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.08070575 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.0903171 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.09166577 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.09196796 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.09213646 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.11667049 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.116947 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.11697678 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.11705805 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.11707333 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.11718493 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.11744662 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.51254264 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.51254354 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.51258511 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.51260258 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.51261028 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.51261948 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.5126276 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.51268172 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.5127895 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.93562734 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.94917891 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.96908218 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.9691463 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.96916436 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.96917084 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.96917851 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.96920124 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.96920399 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.9693083 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.96938473 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 99.98001362 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.0139028 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.0217237 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.0758041 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.0758213 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.0758662 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.0759573 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.1122332 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.1124484 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.1125103 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.1199417 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.509922 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5099931 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5103607 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5103715 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5104012 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5105746 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5106008 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5106102 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.5106527 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9170741 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9320961 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9321211 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9321835 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9322171 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9322484 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.932278 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9323436 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9566034 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9569927 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9571114 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9816636 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 100.9884806 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0034395 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0110924 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0111125 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.011142 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.011283 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0114035 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0118874 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0169747 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0211106 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0352803 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0593093 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0598249 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0711182 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0711455 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0711653 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0711994 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0712548 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0961855 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.0962047 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.1070429 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.5094817 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.509688 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.5098975 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.5102394 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9397474 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9398351 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.939841 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9398656 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9399469 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9399505 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9400294 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9400479 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9498643 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9643491 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9643597 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.964533 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9645766 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9646232 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9646925 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9647367 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9648129 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9652134 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 101.9772762 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0074342 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0111256 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0129338 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0344344 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.055113 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0553938 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0554494 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0722662 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0726052 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0744232 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.0913603 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.1274517 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.1279313 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.1280121 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.128015 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.5093705 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.9475256 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.9482332 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 102.9545936 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0388606 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0391788 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0544001 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0544728 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0549175 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0581641 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.075497 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0755605 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0756224 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0757098 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0757789 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0757995 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0760047 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.0867766 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.1313272 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.9554925 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.955872 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 103.9560711 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.0090613 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.0184211 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.0533439 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.053483 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.0570731 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.0705485 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.0709761 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.1070504 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.1071742 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.1072046 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.1072071 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.1072173 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.5103491 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.9486098 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.9540852 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 104.9930458 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0003821 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0335912 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0336175 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0336256 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0336368 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0336421 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0336479 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0336978 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0337046 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0340336 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0695593 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0699897 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0700707 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0702584 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.0705867 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.070948 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.1104619 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9346594 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9348113 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9348333 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9349154 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9349276 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9350344 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9350583 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9351831 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9541738 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 105.9561661 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.0310334 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.0366134 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.0369293 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.0369515 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.0499499 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.0501906 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.0866049 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.1125696 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.520542 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.591784 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9507164 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9508077 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9670645 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9921043 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9921284 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9921386 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.992175 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9921842 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9922128 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 106.9923307 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0411542 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0478148 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0491053 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0491251 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0492273 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0492436 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0492437 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0492555 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.060716 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0701147 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.070238 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0702712 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0703987 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0704026 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0704654 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0706257 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0706931 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0707998 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0710562 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0711208 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0855608 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.085679 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0857199 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0857385 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.0858877 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 107.9554257 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.0115783 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.0526287 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.0527469 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.0803739 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.0810467 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.5178266 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.5181556 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9490634 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9615359 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9615398 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9615532 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9615754 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9616094 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9616167 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9616247 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9616926 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9617301 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 108.9618091 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.019394 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.0286246 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.0290291 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.0653476 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.065653 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.0748229 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.0762497 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.0762527 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1012387 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1012762 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1013124 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1013296 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1013457 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1013981 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1013994 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1014289 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1014348 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.1014552 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.101474 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.101526 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.5155131 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.5155155 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.5155205 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.5159617 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.9621026 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.9621734 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.9623967 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.9628226 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.9629862 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 109.9687353 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0087507 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0088337 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0088467 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0088763 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0088855 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0089138 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0089156 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0089618 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0090083 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0090709 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0275356 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0714578 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0715426 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0717009 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0729608 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0786291 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.0972226 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.1044995 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.1047549 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.1051895 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.512386 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.9756342 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.9771878 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 110.9773181 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0088145 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0100428 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0122094 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0123836 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0145359 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0157917 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0176467 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0177711 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0205903 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0429568 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0445787 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0554826 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0560464 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0668111 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0745093 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.080516 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0805916 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0805984 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0806426 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0806748 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0811354 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0812969 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0822467 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0919106 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0919369 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.0923995 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1169051 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1169165 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1169484 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1169912 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1170722 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1170765 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1171479 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1171561 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.117249 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.117264 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.1173515 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.5141358 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.5220149 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.968444 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.9688042 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.9688512 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 111.9841865 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.006587 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0074829 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0077267 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.017709 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0179254 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0184241 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0373556 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0498438 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0506958 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0507766 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0512549 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0513932 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0776407 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.0870795 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.1123576 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.1202798 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.1204068 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.5195273 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.8959172 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.9562599 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.9578419 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 112.9669792 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0006493 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0099943 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.017635 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0215208 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.02169 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0229732 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0231487 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0235991 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0236291 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0335247 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0343209 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0345365 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0578743 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0598576 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0601062 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0601314 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0623397 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0699283 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0711305 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.071173 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.0962745 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.1070197 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.1074734 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.1075763 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.107954 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.1325665 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.1326379 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.1326697 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.1326736 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.132707 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9404802 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9405419 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9405546 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.940584 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9405988 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9406381 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9406579 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9406624 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9637724 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.96383 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9638349 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9638604 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9638811 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9639125 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9639182 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9875867 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 113.9954055 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0369467 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.056035 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0561285 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0611032 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0633561 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0654444 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0654922 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0659181 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0663369 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0665074 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0914738 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0915112 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0915864 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0916494 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0917642 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0917705 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.0921604 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.1099983 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.1281985 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.1361031 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.1361127 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.6116146 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.8932787 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.9562167 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.9715628 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.9715874 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.9716159 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.9716568 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.9717155 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.9717242 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 114.987757 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0368622 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0369042 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0381643 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0387338 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0388973 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0700956 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0749198 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0754779 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0758721 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0773434 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0869206 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0881211 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0944188 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.0973049 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.1118612 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.1120691 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.1227847 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.1395725 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.5270085 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.5743079 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.9395088 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.9399577 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.959106 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.9645022 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.9653235 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 115.9893748 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.0166404 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.0166744 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.0345469 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.0346377 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.0697238 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.07084 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.0816467 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.107222 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.1073439 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.114865 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.5181893 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.8911912 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9284062 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.948743 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9527345 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9718276 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9723245 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9725236 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9764538 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.976462 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9764806 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9765086 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9765343 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 116.9839919 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0184528 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0196354 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0384306 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0662924 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0668771 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0668982 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0692861 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0701245 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0703436 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0740111 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0911241 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.091146 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0911948 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0911968 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0913486 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.0915874 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.1026846 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.102939 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.1394516 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9348987 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9349527 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9349981 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9350064 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9350174 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9350675 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9350895 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9588112 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.958926 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9598941 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9799512 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9803419 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 117.9903822 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.05061 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0615367 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0863953 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0864497 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0864593 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0864667 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0864882 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0864958 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.086519 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0865296 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0865474 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0865616 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0865739 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0865993 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0866011 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0866088 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0866833 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.0867605 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.1228404 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.122918 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.8892079 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9206828 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9419006 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9424542 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9424982 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.942524 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9426341 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9426534 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9426693 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9426704 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9669347 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9672192 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9672885 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9718155 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 118.9844105 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0137625 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.014207 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0142197 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.014262 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0143103 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0349698 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0489448 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0520532 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0703695 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.085685 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.086516 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0881686 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0890114 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.0897401 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.1066478 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.5149033 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.958228 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 119.9745385 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0034352 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0102472 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0113221 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0113308 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0113741 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0113908 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0114753 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0116136 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0259201 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0441716 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0453403 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0659294 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0809283 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0809754 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0809898 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0810212 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0810342 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0890777 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.0927024 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.9655921 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.9662939 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells | |||
| AN004246 | 120.9663354 | ST002577 | POSITIVE | Bruker Impact II | Reversed phase | Human | Cultured cells |